Rising Cancer Prevalence Fueling Growth In The Particle Therapy Market: Critical Driver Shaping the Particle Therapy Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Particle Therapy Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there has been considerable growth in the market size of particle therapy. Projections for the market show an expansion from $1.23 billion in 2024 to $1.37 billion in 2025, maintaining a compound annual growth rate (CAGR) of 11.8%. The unprecedented growth seen in the previous period can be credited to factors such as clinical investigations and studies, a rise in cancer cases, governmental aid and financing, collaboration within the industry, and advancements in therapy planning.

Particle Therapy Market Size Forecast: What's the Projected Valuation by 2029?
Rapid expansion is anticipated for the particle therapy market in the forthcoming years. By 2029, it is projected to reach a valuation of $2.19 billion, fuelled by a compound annual growth rate (CAGR) of 12.4%. Elements contributing to this upward trend during the forecast period are increased spending on healthcare, the emergence of uses beyond cancer treatment, an aging demographic, and the development of healthcare infrastructure, as well as the inclusion of AI and data analysis. Key trends anticipated over the forecast period are the upgrade of particle accelerator technology, the development of hypofractionation methods, the combination treatment of proton and carbon ions, enhanced comfort for patients, and the establishment of treatment protocols based on biology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

What Are the Drivers Transforming the Particle Therapy Market?
The particle therapy market is anticipated to grow due to the increasing prevalence of cancer. Cancer, a diverse and complex family of diseases characterized by abnormal cell growth and proliferation in the body, is primarily treated by particle therapy. This method employs precise and effective radiation, accelerating positively charged particles, such as protons, to high speeds before focusing them on the tumour. In April 2024, the France-based International Agency for Research on Cancer (IARC) reported nearly 20 million new cancer cases in 2022, which resulted in nearly 10 million fatalities. Based on demographic trends, the yearly incidence of new cancer cases is expected to surge to 35 million by 2050, a 77% increase from 2022. Consequently, the rise in cancer prevalence is stimulating the growth of the particle therapy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

What Long-Term Trends Will Define the Future of the Particle Therapy Market?
A key trend gaining traction in the particle therapy market is the advancement of particle therapy platforms. Prominent companies in this sector are focusing on developing ground-breaking particle therapy platforms to maintain their market position. For example, in July 2023, RaySearch Laboratories, a medical technology company based in Sweden, introduced RayStation 2023B. This is a holistic oncology treatment planning system boasting several innovative updates in particle therapy, such as discrete proton arcs support and robust optimization based on linear energy transfer (LET). Optimization with LET helps reduce possible side effects by lowering LET in risk organs and directing high LET particles towards tumors to boost tumor control. Discrete proton arc optimization allows a wider range of beam angles resulting in more conformal dose distributions and less risk organ exposure. The software also supports straightforward conversion to standard pencil-beam scanning plans and includes automatic field-in-field planning for photons, point-based optimization for brachytherapy, and improved data loading speeds.

Which Segments in the Particle Therapy Market Offer the Most Profit Potential?
The particle therapy market covered in this report is segmented -

1) By Type: Proton Therapy, Heavy Ion Therapy
2) By System: Single-Room Systems, Multi-Room Systems
3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types
4) By End-User: Hospital, Academic And Research Centers

Subsegments:
1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)
2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy, Other Heavy Ions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12250&type=smp

Which Firms Dominate the Particle Therapy Market by Market Share and Revenue in 2025?
Major companies operating in the particle therapy market include Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

Which Regions Offer the Highest Growth Potential in the Particle Therapy Market?
North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12250

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.